[Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].

Source:http://linkedlifedata.com/resource/pubmed/id/8729191

Download in:

View as

General Info

PMID
8729191